Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
Giuseppe GulloAlexander J EustaceAlexandra CanoniciDenis M CollinsMichael J KennedyLiam GroganOscar BreathhnachJohn McCaffreyMaccon KeaneMichael J MartinRajnish GuptaGregory LeonardMiriam O'ConnorPaula M CalvertPaul DonnellanJanice WalsheEnda McDermottKathleen ScottAndres HernandoImelda ParkerDavid W MurrayAlice C O'FarrellAshwini MarathaPatrick DickerMairin RaffertyVerena MurphyNorma O'DonovanWilliam M GallagherBonnie KyDimitrios TryfonopoulosBrian MoultonAnnette T ByrneJohn CrownPublished in: Therapeutic advances in medical oncology (2019)
ClinicalTrials.gov Identifier: NCT00911716.